Literature DB >> 17383876

Engineering small molecule specificity in nearly identical cellular environments.

Mark A Sellmyer1, Kryn Stankunas, Roger Briesewitz, Gerald R Crabtree, Thomas J Wandless.   

Abstract

Methotrexate (MTX), an inhibitor of dihydrofolate reductase, was tethered to an FKBP12 ligand (SLF), and the resulting bifunctional molecule (MTXSLF) potently inhibits either enzyme but not both simultaneously. MTXSLF is cytotoxic to fibroblasts derived from FKBP12-null mice but is detoxified 40-fold by FKBP12 in wild-type fibroblasts. These studies demonstrate that non-target proteins in an otherwise identical genetic background can be used to predictably regulate the biological activity of synthetic molecules.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17383876      PMCID: PMC1949043          DOI: 10.1016/j.bmcl.2007.03.012

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  12 in total

1.  An efficient proteomics method to identify the cellular targets of protein kinase inhibitors.

Authors:  Klaus Godl; Josef Wissing; Alexander Kurtenbach; Peter Habenberger; Stephanie Blencke; Heidrun Gutbrod; Kostadinos Salassidis; Matthias Stein-Gerlach; Andrea Missio; Matt Cotten; Henrik Daub
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-10       Impact factor: 11.205

2.  Codominant interference, antieffectors, and multitarget drugs.

Authors:  A Varshavsky
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

3.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

Authors:  T Mosmann
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

4.  Wortmannin, a widely used phosphoinositide 3-kinase inhibitor, also potently inhibits mammalian polo-like kinase.

Authors:  Yongsheng Liu; Kevin R Shreder; Wenzhi Gai; Sergio Corral; Douglas K Ferris; Jonathan S Rosenblum
Journal:  Chem Biol       Date:  2005-01

5.  Synthesis and biological activity of DNA damaging agents that form decoy binding sites for the estrogen receptor.

Authors:  S M Rink; K J Yarema; M S Solomon; L A Paige; B M Tadayoni-Rebek; J M Essigmann; R G Croy
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-24       Impact factor: 11.205

6.  The cytosolic-binding protein for the immunosuppressant FK-506 is both a ubiquitous and highly conserved peptidyl-prolyl cis-trans isomerase.

Authors:  J J Siekierka; G Wiederrecht; H Greulich; D Boulton; S H Hung; J Cryan; P J Hodges; N H Sigal
Journal:  J Biol Chem       Date:  1990-12-05       Impact factor: 5.157

7.  Harnessing chaperones to generate small-molecule inhibitors of amyloid beta aggregation.

Authors:  Jason E Gestwicki; Gerald R Crabtree; Isabella A Graef
Journal:  Science       Date:  2004-10-29       Impact factor: 47.728

8.  In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationship.

Authors:  Dirk B Mendel; A Douglas Laird; Xiaohua Xin; Sharianne G Louie; James G Christensen; Guangmin Li; Randall E Schreck; Tinya J Abrams; Theresa J Ngai; Leslie B Lee; Lesley J Murray; Jeremy Carver; Emily Chan; Katherine G Moss; Joshua O Haznedar; Juthamas Sukbuntherng; Robert A Blake; Li Sun; Cho Tang; Todd Miller; Sheri Shirazian; Gerald McMahon; Julie M Cherrington
Journal:  Clin Cancer Res       Date:  2003-01       Impact factor: 12.531

9.  A bifunctional molecule that displays context-dependent cellular activity.

Authors:  Patrick D Braun; Katherine T Barglow; Yun-Ming Lin; Thomas Akompong; Roger Briesewitz; Gregory T Ray; Kasturi Haldar; Thomas J Wandless
Journal:  J Am Chem Soc       Date:  2003-06-25       Impact factor: 15.419

10.  Conditional protein alleles using knockin mice and a chemical inducer of dimerization.

Authors:  Kryn Stankunas; J Henri Bayle; Jason E Gestwicki; Yun-Ming Lin; Thomas J Wandless; Gerald R Crabtree
Journal:  Mol Cell       Date:  2003-12       Impact factor: 17.970

View more
  1 in total

1.  Rational design of novel antiandrogens for neutralizing androgen receptor function in hormone refractory prostate cancer.

Authors:  Pratap Singh; Gurulingappa Hallur; Ravi K Anchoori; Oladapo Bakare; Yukio Kageyama; Saeed R Khan; John T Isaacs
Journal:  Prostate       Date:  2008-10-01       Impact factor: 4.104

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.